BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12393502)

  • 1. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.
    Avet-Loiseau H; Garand R; Lodé L; Harousseau JL; Bataille R;
    Blood; 2003 Feb; 101(4):1570-1. PubMed ID: 12393502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
    Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
    Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.
    Fonseca R; Blood EA; Oken MM; Kyle RA; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Hoyer JD; Harrington D; Kay NE; Van Ness B; Greipp PR
    Blood; 2002 May; 99(10):3735-41. PubMed ID: 11986230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.
    Sasaki K; Lu G; Saliba RM; Bashir Q; Hosing C; Popat U; Shah N; Parmar S; Dinh Y; Ahmed S; Shpall EJ; Kebriaei P; Shah JJ; Orlowski RZ; Champlin R; Qazilbash MH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1227-32. PubMed ID: 23733001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.
    An G; Xu Y; Shi L; Zou D; Deng S; Sui W; Xie Z; Hao M; Chang H; Qiu L
    Leuk Res; 2013 Oct; 37(10):1251-7. PubMed ID: 23927993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.
    Yokoi S; Sakai H; Uchida A; Uemura Y; Sato K; Tsuruoka Y; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Inoue Y; Hoshikawa M; Miura I
    J Clin Exp Hematop; 2015; 55(3):137-43. PubMed ID: 26763361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
    De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
    Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
    Schop RF; Kuehl WM; Van Wier SA; Ahmann GJ; Price-Troska T; Bailey RJ; Jalal SM; Qi Y; Kyle RA; Greipp PR; Fonseca R
    Blood; 2002 Oct; 100(8):2996-3001. PubMed ID: 12351413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
    Garand R; Avet-Loiseau H; Accard F; Moreau P; Harousseau JL; Bataille R
    Leukemia; 2003 Oct; 17(10):2032-5. PubMed ID: 14513054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
    Konduri K; Sahota SS; Babbage G; Tong AW; Kumar P; Newman JT; Stone MJ
    Clin Lymphoma; 2005 Mar; 5(4):285-9. PubMed ID: 15794867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
    Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
    Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant.
    Laï JL; Michaux L; Dastugue N; Vasseur F; Daudignon A; Facon T; Bauters F; Zandecki M
    Cancer Genet Cytogenet; 1998 Jul; 104(2):133-8. PubMed ID: 9666807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12.
    Nishida Y; Takeuchi K; Tsuda K; Ugai T; Sugihara H; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Aug; 91(2):179-82. PubMed ID: 23581835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).
    Feyler S; O'Connor SJ; Rawstron AC; Subash C; Ross FM; Pratt G; Drayson MT; Ashcroft J; Cook G; Owen RG
    Br J Haematol; 2008 Mar; 140(5):547-51. PubMed ID: 18275432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic analysis and fluorescence in situ hybridization in a case of IgD multiple myeloma.
    Weinländer G; Drach J; Raderer M; Okamoto I; Ackermann J; Stögermayer B; Fazeny B; Nowotny H; Marosi C
    Cancer Genet Cytogenet; 1998 Sep; 105(2):172-6. PubMed ID: 9723037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma.
    Meeus P; Stul MS; Mecucci C; Cassiman JJ; Van den Berghe H
    Cancer Genet Cytogenet; 1995 Aug; 83(1):25-7. PubMed ID: 7656199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.